SOPHiA Genetics SA

SOPHiA Genetics SA

SOPH - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$698.9M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
SOPHiA Genetics SASOPHiA Genetics SA-7.5--119%7.41.1
$11.67

Target Price by Analysts

56.8% upsideSOPHiA Genetics SA Target Price DetailsTarget Price

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$698.90 Million
Enterprise Value$682.34 Million
Earnings per Share$-1.17
Beta0.95
Outstanding Shares85,511,332

Return

Return on Equity-118.56%ROE
Return on Assets-43.92%
Return on Invested Capital-57.26%

Valuation & Multiples

P/E Ratio-7.53P/E Ratio
PEG-600.8PEG
Price to Sales7.44Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue7.5
Enterprise Value to EBIT-9.18
Enterprise Value to Net Income-9
Total Debt to Enterprise0.11
Debt to Equity1.13Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 3, 2026
EPS
-$0.24
Est. -$0.20
Revenue
$24.27 M
Est. $24.03 M

Next Earnings Call

Expected Date
March 2, 2027
EPS Estimate
-$0.13
Consensus analyst estimate
Revenue Estimate
$26.24 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls448,100▼ 28.20%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %29.81%▼ 20.09%
Total Invested$184.27M▼ 13.31%
Investors Holding61▼ 14.00%

About SOPHiA Genetics SA

SOPHiA Genetics SA Insider Information FAQ

Stockcircle tracks 9 top investors with a current 13F position in SOPHiA Genetics SA. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 7 top investors increased or opened positions and 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 1 open-market insider purchase and 72 open-market insider sales for SOPHiA Genetics SA in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.